SEARCH

SEARCH BY CITATION

References

  • 1
    National Cancer Institute. The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses. JAMA 1989;262:9314.
  • 2
    The revised Bethesda system for reporting cervical/vaginal cytological diagnoses. Report of the 1991 Bethesda Workshop. Acta Cytol 1992;36: 2736.
  • 3
    Solomon D, Davey D, Kurman R et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002;287:214010.
  • 4
    European Commission. In: European Guidelines for Quality Assurance in Cervical Cancer Screening. ArbynM, AnttilaA, JordanJ, RoncoG, SchenckU, SegnanN, WienerH (eds). Luxembourg: Office of Official Publ EU; 2007 (in press).
  • 5
    Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria and Explanatory Notes, 2nd edn. New York: Springer; 2004.
  • 6
    National Health Service Cervical Screening Programme. Achievable Standards, Benchmarks for Reporting, and Criteria for Evaluating Cervical Cytopathology. Second edition including revised performance indicators. NHSCSP publication 1. Sheffield: NHS Cancer Screening Programmes; 2000: pp. 136.
  • 7
    Wiener HG, Klinkhamer K, Schenck U et al. European guidelines for quality assurance in cervical cancer screening. Cytopathology 2007;18: 6778.
  • 8
    Tambouret R, Pitman M, Bell DA. Benign glandular cells in posthysterectomy vaginal smears. Acta Cytol 1998; 42:14038.
  • 9
    Riotton G, Christopherson WM, Lunt R. Cytology of the Female Genital Tract. Geneva: World Health Organization; 1973.
  • 10
    Richart RM. Cervical intraepithelial neoplasia. Pathol Annu 1973;8:30123.
  • 11
    Herbert A. BSCC terminology for cervical cytology: two or three tiers? Why not five, seven or even 14? Cytopathology 2004;15:24551.
  • 12
    Herbert A. Terms without borders: an international approach to terminology. Diagn Cytopathol 2005;33:3525.
  • 13
    World Health Organization. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
  • 14
    Kocjan G, Priollet BC, Desai M et al. BSCC, Bethesda or other? Terminology in cervical cytology: European panel discussion. Cytopathology 2005;16:1139.
  • 15
    Borderline Nuclear Changes National Slide Exchange Study Group. Quality Assurance Reference Centre for the Trent NHSCSP. Do borderline nuclear changes in gynaecological cytology constitute a reliable reporting category? Cytopathology 2002;13:22031.
  • 16
    Davey DD, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 2000;124:20311.
  • 17
    Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004;96:28093.
  • 18
    Sherman ME, Tabbara SO, Scott DR et al. ‘‘ASCUS, rule out HSIL’’: cytologic features, histologic correlates, and human papillomavirus detection. Mod Pathol 1999;12:33542.
  • 19
    Quddus MR, Sung CJ, Steinhoff MM, Lauchlan SC, Singer DB, Hutchinson ML. Atypical squamous metaplastic cells: reproducibility, outcome, and diagnostic features on ThinPrep Pap test. Cancer 2001;93:1622.
  • 20
    Sherman ME, Solomon D, Schiffman MA. ASCUS LSIL Triage Study Group. Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage study. Am J Clin Pathol 2001;116:38694.
  • 21
    Lee KR, Manna EA, Jones MA. Comparative cytologic features of adenocarcinoma in situ of the uterine cervix. Acta Cytol 1991;35:11726.
  • 22
    Biscotti CV, Gero MA, Toddy SM, Fischler DF, Easley KA. Endocervical adenocarcinoma in situ: an analysis of cellular features. Diagn Cytopathol 1997;17:32632.
  • 23
    Soofer SB, Sidawy MK. Atypical glandular cells of undetermined significance: clinically significant lesions and means of patient follow-up. Cancer 2000;90:20714.
  • 24
    Montz FJ. Significance of ‘‘normal’’ endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy. Gynecol Oncol 2001;81:339.
  • 25
    Fadare O, Ghofrani M, Chacho MS, Parkash V. The significance of benign endometrial cells in cervicovaginal smears. Adv Anat Pathol 2005;12:27487.